The role of echo-cardiography in the management of patients with congestive heart failure: “Tanzanian experience"

A CAJM clinical study on heart- failure management in a Tanzania hospital using an Echocardiography .Congestive heart failure (CHF) is a major public health problem that is associated with markedly diminished survival.1,2 The reported proportion of CHF patients with normal left ventricular systolic function has ranged from 13% to 75% and the reported annual mortality rate has varied from 1.3% to 17.5%.3 This implies that abnormal left ventricular diastolic function is the mechanism responsible for producing congestive symptoms in these patients.3 The approach to treatment may differ depending on whether systolic or diastolic dysfunction is predominant. Because clinical findings fail to distinguish patients with systolic or diastolic dysfunction/ several institutions recommend echocardiography in all patients with suspected congestive heart failure.5 Unfortunately, no data are available on use and outcome of patients studied with echocardiography, in the management of congestive heart failure in our region. Therefore, we prospectively assessed the relative proportions of normal versus impaired left ventricular systolic function among persons with CHF in a hospital based study sample and assessed the risks of mortality and heart failure re-admissions during follow up

Evaluation of sixteen years of INGV seismic Bulletins

In this work we analyze earthquake parameters published in the Seismic Bulletin of the Istituto Nazionale di Geofisica e Vulcanologia (INGV) The analysis and the interpretation of the digital signals, done by specialized employees daily, produce most of the seismological information that comprises INGV's earthquake bulletins. After a brief introduction on the criteria we use to obtain seismic parameters, this paper will review the processing procedures employed over a period of sixteen years from 1988 to September 2003. This study also addresses the issue of the comparison between Magnitude calculated on signal duration (Md) and on amplitude (ML) and the lack of a correct calibration between them . A completeness analysis of the whole bulletin performed using both the Stepp and the Habermann techniques shows the importance of considering changes in the seismicity rate and in the geometry of the seismological network. To conclude this excursus, we calculated the errors of hypocentral locations and the detection capacity of individual seismic stations. This final step stresses the increasing improvement of the INGV seismic network over the past 16 years

LA RETE SISMICA DELLA PIANA DI GUIDONIA (LAZIO): DATI PRELIMINARI

After the seismic period during 2001-2002 that has interested the Plain of Guidonia, situated about fifteen kilometres NE of Rome, which events greatest resentment reached the V-VI MCS, have been installed a local seismic purchased by Comune of Guidonia-Montecelio (Rm). The seismic network (RLG) consists of three digital seismic stations with distances of each other about 2 kilometers, activated to leave from the June 2004 and equipped with three components 1 Hz sismometer. Subsequently, the RLG has enriched of other four digital stations equipped with three components 5 Hz sismometer This network has like main objective the high quality data that agree a better definition of the seismic local activity. These data, that integrate those of the Seismographic Centralized National Network (SCNN), agreed a better ipocentre location. Network geometriy was chosen so as to give back the RLG an independent structure to carry out reliable seismicity locations that characterizes the plain of Guidonia. Unfortunately, industrial and human activity, increases in considerable manner the seismic noise, giving back difficult the record of small events. For this motive the location of the sites was more times changed, and lately, after a seismic crisis in the northern side of the Mountains Cornicolani, that has presented with the same features of that of 2001 of Guidonia, some stations were moved in the neighboring village of Palombara Sabina (Rm)

Recent seismicity of the «Acque Albule» travertine basin

The seismic period which occurred in a portion of Guidonia Montecelio and Tivoli territory, two towns situated about twenty kilometres NE of Rome, affected four areas with a high density of population: Guidonia, Collefiorito, Villalba and Bagni di Tivoli. Even though the events had a very low magnitude (less than 3.0), local phenomena, like rumbles and strong vibrations of the ground, frightened inhabitants also because some months before (January 26, 2001) in a village named Marcellina situated a few kilometres away from Guidonia, a large sinkhole (600 m) had appeared without fore signals. The «Istituto Nazionale di Geofisica e Vulcanologia» (INGV) installed some digital stations that monitored the seismic phenomena. This paper has the aim to process all the information acquired during the period, both from the micro and macro seismic point of view, in order to explain the phenomenology that involved the area. The synergy of the two methodologies lead us to the conclusion that two different seismotectonic structures originated the events, one in an anti-apenninic direction, the other in a N-S direction

Inducible antiviral activity and rapid production of the Ribosome-Inactivating Protein I from Phytolacca heterotepala in tobacco

We studied the in vitro and in planta antiviral activity of the PhRIP I, a type 1 Ribosome-Inactivating Protein originally purified from leaves of the Phytolacca heterotepala. This protein inhibited protein translation in a cell-free assay and limited the local lesion formation from PVX infection on tobacco leaves. We used a transient expression system based on leaf infiltration with recombinant Agrobacteria to show that tobacco can produce a correctly processed PhRIP I enzyme that retains its antiviral activity. Hence, it is possible to rapidly yield in plants a type 1 RIP by means of this transient expression system. To analyse the possible increase of virus resistance in plants, Nicotiana tabacum lines that were transformed with the PhRIP I coding sequence under the control of the wound-inducible PGIP promoter were challenged by PVX. A significantly lower number of viral lesions compared to untransformed plants was observed only after the induction of the transgene, indicating that the controlled gene expression of an antiviral protein can increase virus resistance

Ageritin from pioppino mushroom: The prototype of ribotoxin-like proteins, a novel family of specific ribonucleases in edible mushrooms

Ageritin is a specific ribonuclease, extracted from the edible mushroom Cyclocybe aegerita (synonym Agrocybe aegerita), which cleaves a single phosphodiester bond located within the uni-versally conserved alpha-sarcin loop (SRL) of 23–28S rRNAs. This cleavage leads to the inhibition of protein biosynthesis, followed by cellular death through apoptosis. The structural and enzy-matic properties show that Ageritin is the prototype of a novel specific ribonucleases family named ‘ribotoxin-like proteins’, recently found in fruiting bodies of other edible basidiomycetes mushrooms (e.g., Ostreatin from Pleurotus ostreatus, Edulitins from Boletus edulis, and Gambositin from Calocybe gambosa). Although the putative role of this toxin, present in high amount in fruiting body (>2.5 mg per 100 g) of C. aegerita, is unknown, its antifungal and insecticidal actions strongly support a role in defense mechanisms. Thus, in this review, we focus on structural, biological, antipathogenic, and enzymatic characteristics of this ribotoxin-like protein. We also highlight its biological relevance and potential biotechnological applications in agriculture as a bio-pesticide and in biomedicine as a therapeutic and diagnostic agent

Incidence of human brucellosis in the Kilimanjaro Region of Tanzania in the periods 2007-2008 and 2012-2014

Background: Brucellosis causes substantial morbidity among humans and their livestock. There are few robust estimates of the incidence of brucellosis in sub-Saharan Africa. Using cases identified through sentinel hospital surveillance and health care utilization data, we estimated the incidence of brucellosis in Moshi Urban and Moshi Rural Districts, Kilimanjaro Region, Tanzania, for the periods 2007–2008 and 2012–2014. Methods: Cases were identified among febrile patients at two sentinel hospitals and were defined as having either a 4-fold increase in Brucella microscopic agglutination test titres between acute and convalescent serum or a blood culture positive for Brucella spp. Findings from a health care utilization survey were used to estimate multipliers to account for cases not seen at sentinel hospitals. Results: Of 585 patients enrolled in the period 2007–2008, 13 (2.2%) had brucellosis. Among 1095 patients enrolled in the period 2012–2014, 32 (2.9%) had brucellosis. We estimated an incidence (range based on sensitivity analysis) of brucellosis of 35 (range 32–93) cases per 100 000 persons annually in the period 2007–2008 and 33 (range 30–89) cases per 100 000 persons annually in the period 2012–2014. Conclusions: We found a moderate incidence of brucellosis in northern Tanzania, suggesting that the disease is endemic and an important human health problem in this area

Prevalence of obesity and obesity-associated muscle wasting in patients on peritoneal dialysis

Background and aims: A progressive decrease in muscle mass until full-blown sarcopenia may occur in patients on peritoneal dialysis (PD) and worsen their life quality and expectancy. Here we investigate the prevalence of obesity and obesity-associated muscle wasting in PD patients. Patients and methods: The study design was observational, cross sectional. Body composition was assessed with BIA and BIVA in 88 PD patients (53.4 ± 13.1 years; 67% male). Patients with obesity and/or with reduced muscle mass were identified using FMI and SM/BW cutoff values, respectively. Inflammatory status was assessed by measuring CRP and fibrinogen blood levels. Results: A total of 44.3% of the patients showed a reduced muscle mass (37.5% moderate and 6.8% severe). The prevalence of obesity was 6.1%, 81.8%, and 100% in patients with normal, moderately, and severely reduced muscle mass, respectively (p < 0.05). Of the total, 15.2% of the patients with normal muscle mass, 18.4% of those with moderately reduced muscle mass, and 66.7% of those with severely reduced muscle mass had diabetes. The prevalence of severe muscle mass loss was higher in those with diabetes than in those without diabetes (22.2% vs. 2.8%, p < 0.05). Patients with obesity-associated muscle wasting showed higher fibrinogen (613.9 ± 155.1 vs. 512.9 ± 159.5 mg/dL, p < 0.05) and CPR (1.4 ± 1.3 vs. 0.6 ± 0.8 mg/dL, p < 0.05) blood concentrations than those with normal body composition. Conclusion: Obesity and diabetes were strongly associated with muscle mass loss in our PD patients. It remains to be established whether prevention of obesity with nutritional interventions can halt the occurrence of muscle mass loss in patients on PD

Cytotoxicity effect of quinoin, type 1 ribosome-inactivating protein from quinoa seeds, on glioblastoma cells

Ribosome-inactivating proteins (RIPs) are found in several edible plants and are well characterized. Many studies highlight their use in cancer therapy, alone or as immunoconjugates, linked to monoclonal antibodies directed against target cancer cells. In this context, we investigate the cytotoxicity of quinoin, a novel type 1 RIP from quinoa seeds, on human continuous and primary glioblastoma cell lines. The cytotoxic effect of quinoin was assayed on human continuous glioblas-toma U87Mg cells. Moreover, considering that common conventional glioblastoma multiforme (GBM) cell lines are genetically different from the tumors from which they derive, the cytotoxicity of quinoin was subsequently tested towards primary cells NULU and ZAR (two cell lines established from patients’ gliomas), also in combination with the chemotherapeutic agent temozolomide (TMZ), cur-rently used in glioblastoma treatment. The present study demonstrated that quinoin (2.5 and 5.0 nM) strongly reduced glioblastoma cells’ growth. The mechanisms responsible for the inhibitory action of quinoin are different in the tested primary cell lines, reproducing the heterogeneous response of glioblastoma cells. Interestingly, primary cells treated with quinoin in combination with TMZ were more sensitive to the treatment. Overall, our data highlight that quinoin could represent a novel tool for glioblastoma therapy and a possible adjuvant for the treatment of the disease in combination with TMZ, alone or as possible immunoconjugates/nanoconstructs